You Searched For "Bharat Biotech"

Covaxin gets govt nod for emergency use on 12-18 age group
Covaxin gets govt nod for emergency use on 12-18 age group

Covaxin is formulated uniquely such that the same dosage can be administered to adults and children, Hyderabad vaccine maker said in a statement here...

By Newsmeter Network  Published on 26 Dec 2021 5:21 AM GMT


`Vaccine diplomacy: Hyderabad-based Bharat Biotech to donate 2L `Covaxin doses to Vietnam
`Vaccine diplomacy': Hyderabad-based Bharat Biotech to donate 2L `Covaxin' doses to Vietnam

Hyderabad-based Bharat Biotech will donate two lakh doses of `Covaxinā€™ to the Republic of Vietnam.

By Newsmeter Network  Published on 17 Dec 2021 3:21 AM GMT


Bharat Biotechs `Covaxin only vaccine to be 65.2% effective against Delta variant: The Lancet
Bharat Biotech's `Covaxin' only vaccine to be 65.2% effective against Delta variant: The Lancet

The safety and efficacy analysis data from Phase III clinical trials of Covaxin has been peer-reviewed and published in The Lancet.

By Newsmeter Network  Published on 12 Nov 2021 2:57 AM GMT


WHO approves Hyd based Bharat Biotechs Covaxin for Emergency Use Listing
WHO approves Hyd based Bharat Biotech's Covaxin for Emergency Use Listing

The WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson & Johnson-Janssen, Moderna, and...

By Newsmeter Network  Published on 3 Nov 2021 11:59 AM GMT


Australia adds Bharat Biotechs Covaxin to list of recognized vaccines
Australia adds Bharat Biotech's Covaxin to list of 'recognized' vaccines

The TGA of the ministry of health of the Australian government, in a statement, said, ā€œCovaxin would be ā€˜recognizedā€™ for the purpose of establishing a...

By Newsmeter Network  Published on 1 Nov 2021 10:44 AM GMT


Need additional clarifications on `Covaxin before EUL: WHO to Hyd-based Bharat Biotech
Need additional clarifications on `Covaxin' before EUL: WHO to Hyd-based Bharat Biotech

The technical advisory group will now meet on November 3 for a final risk-benefit assessment.

By Newsmeter Network  Published on 27 Oct 2021 2:49 AM GMT


Phase 2/3 trials of `Covaxin for use in children completed:  Bharat Biotech MD
Phase 2/3 trials of `Covaxin' for use in children completed: Bharat Biotech MD

The company is expected to submit the data by next week to the DCGI, chairman and managing director of Bharat Biotech International Ltd Krishna Ella...

By Newsmeter Network  Published on 22 Sep 2021 4:11 AM GMT


Bharat Biotech releases first commercial batch of Covaxin from its Ankleshwar plant
Bharat Biotech releases first commercial batch of Covaxin from its Ankleshwar plant

The Union minister for health and family welfare, Mansukh Mandaviya, released the first commercial batch of Covaxin from Bharat Biotechā€™s Chiron...

By Newsmeter Network  Published on 29 Aug 2021 8:31 AM GMT


Hyderabad: IVI, Bharat Biotech launch phase II trial of Chikungunya vaccine in Costa Rica
Hyderabad: IVI, Bharat Biotech launch phase II trial of Chikungunya vaccine in Costa Rica

International Vaccine Institute (IVI) on Wednesday said Bharat Biotech's Chikungunya vaccine candidate (BBV87) was administered to first volunteer in...

By Newsmeter Network  Published on 25 Aug 2021 8:16 AM GMT


Hyd-based Bharat Biotechs nasal vaccine gets approval for phase II-III trials
Hyd-based Bharat Biotech's nasal vaccine gets approval for phase II-III trials

Bharat Biotech's intranasal vaccine has received regulatory approval for phase II and III trials. This is a first-of-its-kind COVID-19 jab to undergo...

By Newsmeter Network  Published on 13 Aug 2021 1:31 PM GMT


Hyd-based Bharat Biotechs rotavirus vaccine Rotovac 5D gets WHO pre-qualification
Hyd-based Bharat Biotech's rotavirus vaccine 'Rotovac 5D' gets WHO pre-qualification

Hyderabad: Bharat Biotech on Monday announced that the World Health Organization (WHO) has awarded prequalification to its rotavirus vaccine, Rotavac...

By Newsmeter Network  Published on 2 Aug 2021 2:30 PM GMT


Hyderabad-based Bharat Biotechs Covaxin effective against Delta Plus: ICMR
Hyderabad-based Bharat Biotech's Covaxin effective against Delta Plus: ICMR

A study by the Indian Council of Medical Research (ICMR) said that Covaxin, India's first indigenous vaccine to fight COVID-19, is effective against...

By Newsmeter Network  Published on 2 Aug 2021 11:05 AM GMT


Share it